During a recent roundtable discussion, leading experts in the fields of veterinary parasitology, dermatology, behavior, and client communication gathered to discuss parasite control opportunities in clinical practice.
Vector-borne diseases have taken on increasing importance in both veterinary and human medicine as new diseases continue to become recognized and established, vector populations spread, and the potential for transmission of infectious diseases between people and pets is increasingly understood.
Testing for Lyme disease and anaplasmosis often involves detection of antibodies. Antibodies may be detected on a patient-side assay such as the 3Dx/4Dx SNAP tests or using IFA at a reference lab. The SNAP test uses C6 as the target antigen and thus the B. burgdorferi result is very specific.
In many areas of the US, tick populations are dense, and at certain times of the year and when climatic factors are ideal, tick activity may be very high, overwhelming the ability of an acaricide to control ticks on dogs.
Vector-borne diseases in general, and tick-borne diseases in particular, are increasingly recognized as important in both veterinary medicine and public health. In recent years, new disease agents have been identified in both dogs and people, tick populations have increased in number and extent of geographic distribution, and the potential for transmission of disease agents to people and dogs appears to be increasing.
The common ticks on dogs and cats in North America are all three host ticks. Accordingly, the larvae, nymphs, and adults of each species must each quest, attach to a host, and feed before leaving the host to molt or deposit eggs in the environment.
Despite the advent of highly effective, easily administered broad-spectrum parasite control products for cats, infection with intestinal parasites in general, and ascarids (roundworms) in particular, remains a common finding in cats.